CN105919931B - 一种稳定的盐酸法舒地尔注射液及其制备方法 - Google Patents
一种稳定的盐酸法舒地尔注射液及其制备方法 Download PDFInfo
- Publication number
- CN105919931B CN105919931B CN201610411554.XA CN201610411554A CN105919931B CN 105919931 B CN105919931 B CN 105919931B CN 201610411554 A CN201610411554 A CN 201610411554A CN 105919931 B CN105919931 B CN 105919931B
- Authority
- CN
- China
- Prior art keywords
- injection
- fasudil hydrochloride
- preparation
- hydrochloride injection
- fasudil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610411554.XA CN105919931B (zh) | 2016-06-12 | 2016-06-12 | 一种稳定的盐酸法舒地尔注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610411554.XA CN105919931B (zh) | 2016-06-12 | 2016-06-12 | 一种稳定的盐酸法舒地尔注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105919931A CN105919931A (zh) | 2016-09-07 |
CN105919931B true CN105919931B (zh) | 2017-10-27 |
Family
ID=56833690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610411554.XA Active CN105919931B (zh) | 2016-06-12 | 2016-06-12 | 一种稳定的盐酸法舒地尔注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105919931B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107854429A (zh) * | 2017-12-25 | 2018-03-30 | 南京正科医药股份有限公司 | 一种右旋酮洛芬氨丁三醇注射液及其制备工艺 |
CN108042487A (zh) * | 2018-01-26 | 2018-05-18 | 南京正科医药股份有限公司 | 一种右旋酮洛芬氨丁三醇注射剂及其制备方法 |
CN109568277B (zh) * | 2019-01-30 | 2022-06-21 | 成都欣捷高新技术开发股份有限公司 | 枸橼酸在制备帕瑞昔布钠冻干制剂组合物中的应用及其组合物和制备方法 |
CN113197848B (zh) * | 2021-05-24 | 2023-06-09 | 成都欣捷高新技术开发股份有限公司 | 一种重酒石酸间羟胺药物组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104644551B (zh) * | 2015-02-06 | 2017-11-28 | 成都国为生物医药有限公司 | 一种供注射用的含有盐酸法舒地尔的药物组合物 |
CN104840418B (zh) * | 2015-06-11 | 2018-01-12 | 山东新时代药业有限公司 | 一种盐酸法舒地尔注射液组合物及其制备方法 |
-
2016
- 2016-06-12 CN CN201610411554.XA patent/CN105919931B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN105919931A (zh) | 2016-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105919931B (zh) | 一种稳定的盐酸法舒地尔注射液及其制备方法 | |
US9050307B2 (en) | Method for the preparation of a levothyroxine solution | |
CN106659711A (zh) | 呈现长期稳定性的褪黑素注射剂的持久制剂 | |
CN101455631B (zh) | 环磷腺苷葡胺注射液及其制备工艺 | |
WO2016137969A2 (en) | Liquid levothyroxine formulations | |
JP2014237607A (ja) | ペメトレキセドを含む注射用組成物 | |
WO2014118040A1 (en) | Extract from indigo tinctoria for the topical treatment and prophylaxis of skin disorders | |
KR20160137584A (ko) | 실데나필 용액 그리고 이의 제조 및 사용 방법 | |
CN106959347B (zh) | 环磷腺苷葡胺注射液药物组合物的质控方法 | |
Kling et al. | Rat brain and serum lithium concentrations after acute injections of lithium carbonate and orotate | |
CN111374942B (zh) | 一种甾体类肌松药注射液及其制备方法 | |
CN104706655B (zh) | 注射用环磷腺苷葡胺粉针剂药物组合物和制法 | |
CN102233130B (zh) | 稳定的含有胸腺肽1衍生物的药物制剂 | |
CN102068408A (zh) | 一种盐酸法舒地尔注射液及其制备方法 | |
CN102652744A (zh) | 一种改进的13种复合维生素注射液及其制备方法 | |
CN107019675A (zh) | 注射用环磷腺苷冻干粉针剂药物组合物及质控方法和制法 | |
CN102258463A (zh) | 一种稳定的亚叶酸钠注射液 | |
WO2020011753A1 (en) | Compositions for therapeutic uses containing 5-htp and carbidopa | |
CN102600143B (zh) | 长春西汀药物组合物及其制备方法 | |
CN110314132B (zh) | 一种门冬氨酸鸟氨酸注射液及其制备方法 | |
BG66612B1 (bg) | Фармацевтичен състав на разтвор за перорални капки, съдържащ метамизол | |
CN103432067A (zh) | 酮洛芬溶液及其制备方法 | |
US20200138709A1 (en) | Pharmaceutical composition in the form of an aqueous solution, 1a syrup, containing inosine pranobex and zinc gluconate and a method of preparation thereof | |
CN103462888B (zh) | 一种取代的β-环糊精包合的长春西汀注射液及其制备方法 | |
RU2815979C1 (ru) | Интраназальная композиция, содержащая соединения полидигидроксифенилентиосульфоната натрия (ПДФН) и L-триптофан, и способ получения композиции. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 510623 Guangdong city of Guangzhou province Tianhe District Xian Cun Lu No. 5 room 3001-3006 Applicant after: Guangdong Zhong run Medicine Co.,Ltd. Address before: 1002-1004 room 69, Dongshan Plaza, No. 510000 martyrs Road, Guangzhou, Guangdong, Yuexiu District Applicant before: GUANGDONG SUNSHINE PHARMACEUTICAL Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200310 Address after: 510623 Layer 3612, Kaihua International Center, No. 5 Xiancun Road, Tianhe District, Guangzhou City, Guangdong Province Patentee after: GUANGDONG ZHONGRUN DRUG DEVELOPMENT Co.,Ltd. Address before: 510623 Guangdong city of Guangzhou province Tianhe District Xian Cun Lu No. 5 room 3001-3006 Patentee before: Guangdong Zhong run Medicine Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Room 601, Building A3, No. 11 Kaiyuan Avenue, Huangpu District, Guangzhou City, Guangdong Province, 510700 Patentee after: Zhongrun Pharmaceutical Co.,Ltd. Address before: 510623 3612, 36F, Kaihua International Center, No.5 Xiancun Road, Tianhe District, Guangzhou City, Guangdong Province Patentee before: GUANGDONG ZHONGRUN DRUG DEVELOPMENT Co.,Ltd. |
|
CP03 | Change of name, title or address |